回盛生物 (300871.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

财务分析(报告期)(回盛生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
主要指标:
 营业收入(元) 691,386,248.86449,082,426.69230,412,076.041,022,900,792.34671,478,771.75397,018,762.74205,665,754.61
 营业利润(元) 16,989,095.0019,616,786.5216,619,294.4659,156,949.3330,433,524.1610,365,515.084,799,097.26
 利润总额(元) 14,640,631.1817,363,212.1316,631,467.4856,709,500.4028,460,408.218,404,894.742,793,791.45
 净利润(元) 14,877,358.4115,897,944.1614,855,718.0052,706,475.4826,405,977.466,512,643.752,023,854.94
 归属于母公司股东的净利润(元) 14,877,358.4115,897,944.1614,855,718.0052,706,475.4826,405,977.466,512,643.752,023,854.94
盈利能力:
 销售毛利率(%) 21.2122.3424.1822.0320.4619.2120.17
 销售净利率(%) 2.153.546.455.153.931.640.98
 净资产收益率(%) 0.971.030.95----
 总资产报酬率ROA(%) 1.000.930.76----
 投入资本回报率ROIC(%) 0.600.630.582.111.060.270.08
营运能力:
 存货周转率(次) 2.611.470.83----
 应收账款周转率(次) 2.391.640.80----
 总资产周转率(次) 0.240.160.08----
偿债能力:
 资产负债率(%) 48.2249.3148.5448.4343.7241.6242.02
 股东权益比率(%) 51.7850.6951.4651.5756.2858.3857.98
 已获利息倍数(倍) 2.072.924.295.024.083.977.12
 流动比率 1.671.651.691.682.222.582.66
 速动比率 1.331.331.401.421.892.112.27
发展能力:
 营业收入增长率(%) 2.9613.1112.032.68-9.98-25.89-34.40
 营业利润增长率(%) -44.1889.25246.30-60.83-77.97-91.23-93.48
 税后利润增长率(%) -43.66144.11634.03-60.33-77.95-93.57-96.81
 净资产增长率(%) -3.34-3.65-0.65-4.787.219.088.58
 总资产增长率(%) 5.0610.9611.959.0340.2942.8051.06

前瞻产业研究院